Corcept Therapeutics
Meghan McBreen Moreau currently serves as the Manager of Clinical Quality Assurance at Corcept Therapeutics, where responsibilities include providing GCP compliance support for clinical study teams, managing GCP audits, and overseeing study-specific audit plans using a risk-based approach. Previously, Meghan held the position of Senior Clinical Quality Assurance Specialist at Neuralink and returned to Corcept Therapeutics as Manager of Clinical Quality Assurance after an initial tenure in the same role. Meghan's earlier experience includes over a decade in clinical quality management at Family Health Centers of San Diego and project management roles at Merck, where the oversight of early phase clinical trials was a key focus. Meghan's academic background includes a Bachelor of Arts from College of the Holy Cross and a Master of Public Health in Epidemiology from Rutgers School of Public Health.
This person is not in any teams
Corcept Therapeutics
4 followers
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.